Yoshinao Oda

<i><scp>ALK</scp></i>,<i><scp>ROS</scp>1</i> and <i><scp>NTRK</scp>3</i> gene rearrangements in inflammatory myofibroblastic tumours

Hidetaka Yamamoto, Akihiko Yoshida, Kenichi Taguchi et al. · Histopathology · 2015 · 209 citations

Medicine, Oncology, Pathology +17

Prognostic Significance of AKT/mTOR and MAPK Pathways and Antitumor Effect of mTOR Inhibitor in NF1-Related and Sporadic Malignant Peripheral Nerve Sheath Tumors

Makoto Endo, Hidetaka Yamamoto, Nokitaka Setsu et al. · Clinical Cancer Research · 2012 · 138 citations

Medicine, Oncology, Pathology +17

Histological and immunohistochemical characteristics of undifferentiated small round cell sarcomas associated with CIC-DUX4 and BCOR-CCNB3 fusion genes

Yuichi Yamada, Masaaki Kuda, Kenichi Kohashi et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2017 · 103 citations

Medicine, Cancer Biology, Oncology +15

Cancer‐testis antigens PRAME and NY‐ESO‐1 correlate with tumour grade and poor prognosis in myxoid liposarcoma

Kunio Iura, Kenichi Kohashi, Yuka Hotokebuchi et al. · The Journal of Pathology Clinical Research · 2015 · 78 citations · Full text

Medicine, Oncology, Pathology +17

<i><scp>HER</scp>2</i> and <i><scp>EGFR</scp></i> gene copy number alterations are predominant in high‐grade salivary mucoepidermoid carcinoma irrespective of <i><scp>MAML</scp>2</i> fusion status

Takafumi Nakano, Hidetaka Yamamoto, Kazuki Hashimoto et al. · Histopathology · 2013 · 55 citations

Medicine, Molecular Biology, Oncology +17